Novateur study points toward potential COVID-19 treatment
Researchers at Novateur Ventures have released a strategy that examines leukotrienes as the cause for hyperinflammatory response in severe cases.
Archives for August 17, 2020
Phesi adds country selection to trial site platform
The company’s AI-powered Clinsite investigator site intelligence platform now offers country selection, designed to help streamline trial efficiency.
Mission Bio raises $70m to help develop cancer therapies
The company has landed $70m in Series C funding, with the purpose of accelerating development of cancer therapies with single-cell multiomics.